Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
The website http://www.palliativedrugs.com has provided essential independent information about drugs used in palliative and hospice care for over a decade, and has over 30 000 members from 169 countries. It contains the online Palliative Care Formulary (PCF) and provides free access to a Bulletin board to stimulate questions and share experiences, a Document library containing 475 items of useful information and a Syringe Driver Survey Database containing details of over 2350 different drug combinations. Territory-specific book versions (the UK Palliative Care Formulary 5th edition, Hospice and Palliative Care Formulary USA 2nd edition and Palliative Care Formulary Canadian edition) a PDF version of the PCF and subscription to the continually updated online PCF can also be purchased via the website. This feature provides a selection of items that have featured in the News and Latest additions sections in recent months; for additional information, please register for free on the website.
Potential risk of error in selecting incorrect oxycodone strength
The UK National Pharmacy Association has warned that incidents have occurred involving the selection of the wrong strength of oxycodone oral solution by prescribers on Egton Medical Information Systems (EMIS), used by general practitioner surgeries. This appears to be due to the fact that the oxycodone 10 mg/mL solution appears as the first option before the oxycodone 5 mg/5 mL solution. Pharmacists are being advised to confirm all prescriptions for the 10 mg/mL solution are correct.
Codeine for cough and cold contraindicated for children under 12 years
Codeine for cough and cold is now contraindicated in children under 12 years, and not recommended in children between 12 and 18 years with compromised respiratory function in the UK. A European review confirmed …